Infection prevention and control in patients with cystic fibrosis (CF): Results from a survey in 35 German CF treatment centers

Sonja Meyer; Thomas Nüßlein; Lutz Nährlich; Jutta Bend; Barbara Gärtner; Sören L Becker; Arne Simon

doi:10.1016/j.jcf.2019.10.012

Infection prevention and control in patients with cystic fibrosis (CF): Results from a survey in 35 German CF treatment centers

J Cyst Fibros. 2020 May;19(3):384-387. doi: 10.1016/j.jcf.2019.10.012. Epub 2019 Oct 31.

Authors

Sonja Meyer¹, Thomas Nüßlein², Lutz Nährlich³, Jutta Bend⁴, Barbara Gärtner⁵, Sören L Becker⁶, Arne Simon⁷

Affiliations

¹ Department of Pediatric Hematology and Oncology, Children's Hospital Medical Center, University Hospital of Saarland, Kirrberger Str. Building 9, 66421 Homburg/Saar, Germany. Electronic address: [email protected].
² Gemeinschaftsklinikum Mittelrhein -Klinik für Kinder- und Jugendmedizin, Koblenzer Str. 115-155, 56073 Koblenz, Germany. Electronic address: [email protected].
³ Department of Pediatrics, Justus-Liebig-University Giessen, Feulgenstr. 12, 35385 Giessen, Germany. Electronic address: [email protected].
⁴ Mukoviszidose e.V. & Mukoviszidose Institut gGmbH In den Dauen 6, 53117 Bonn, Germany. Electronic address: [email protected].
⁵ Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Str., Building 43, 66421 Homburg/Saar, Germany. Electronic address: [email protected].
⁶ Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Str., Building 43, 66421 Homburg/Saar, Germany. Electronic address: [email protected].
⁷ Department of Pediatric Hematology and Oncology, Children's Hospital Medical Center, University Hospital of Saarland, Kirrberger Str. Building 9, 66421 Homburg/Saar, Germany. Electronic address: [email protected].

PMID: 31680044
DOI: 10.1016/j.jcf.2019.10.012

Abstract

This survey evaluates whether the Cystic Fibrosis (CF)-specific infection prevention and control (IPC) recommendations released by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) in 2012 have been implemented in specialized German CF facilities. Of 35 participating centers (response rate 32.7%), 37% care for more than 100 patients and 44% treat mainly adults. Clinics for adult CF patients report a shortage of qualified personnel for intensified environmental cleaning. Some hospitals struggle to provide single patient rooms with an adjacent sanitary area to segregate CF patients strictly. Most centers offer at least one decolonization cycle (including systemic and inhalative antibiotics) to patients colonized with MRSA. In CF centers in Germany, the KRINKO IPC recommendations are considered helpful by the attending physicians and thoroughly implemented. There is room for improvement concerning strict segregation of inpatients with CF in single patient rooms, in particular in large CF centers mainly caring for adults.

Keywords: Commission for hygiene and infection control; Cystic fibrosis; Infection prevention and control; Pseudomonas aeruginosa; Segregation; Survey.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Cross Infection / prevention & control
Cystic Fibrosis* / epidemiology
Cystic Fibrosis* / microbiology
Cystic Fibrosis* / therapy
Environmental Monitoring / methods
Environmental Monitoring / standards
Female
Germany / epidemiology
Guideline Adherence / standards
Health Care Surveys
Health Services Needs and Demand
Health Workforce / standards
Hospitals, Special* / organization & administration
Hospitals, Special* / standards
Humans
Male
Patient Isolation / organization & administration*
Pseudomonas Infections* / epidemiology
Pseudomonas Infections* / prevention & control
Pseudomonas Infections* / therapy
Pseudomonas aeruginosa / isolation & purification*
Respiratory Tract Infections* / epidemiology
Respiratory Tract Infections* / microbiology
Respiratory Tract Infections* / prevention & control